ABOHNS Sleep Medicine flashcards
ABOHNS Sleep Medicine · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Slow-wave sleep
- NREM stage N3, defined by high-amplitude delta waves; it predominates in the first third of the night and is linked to restoration and memory consolidation.
- Orexin (hypocretin)
- Lateral hypothalamic neuropeptide that stabilizes wakefulness; its deficiency causes narcolepsy type 1 with cataplexy and low CSF hypocretin-1.
- Process S and Process C
- Two-process model in which homeostatic sleep pressure (Process S) and circadian timing (Process C) interact to determine sleep propensity and timing.
- K-complex
- A high-amplitude biphasic EEG wave that, along with sleep spindles, defines NREM stage N2 sleep.
- Apnea-hypopnea index
- Number of apneas plus hypopneas per hour of sleep; severity is mild 5-14.9, moderate 15-29.9, and severe 30 or more.
- STOP-BANG questionnaire
- Eight-item screening tool for OSA risk; a score of 3 or more suggests elevated risk and supports further testing.
- Home sleep apnea testing
- Limited-channel testing used for adults with high pretest probability of moderate-to-severe OSA; negative results in high-risk patients warrant in-lab polysomnography.
- Multiple sleep latency test
- Daytime nap study measuring sleep latency and REM onset; mean latency of 8 minutes or less with two or more SOREMPs supports narcolepsy.
- Maintenance of wakefulness test
- Objective test of ability to remain awake in a quiet setting; used to assess treatment response and fitness for duty, not to diagnose narcolepsy.
- Actigraphy
- Wrist-worn movement monitor that estimates sleep-wake patterns over days to weeks; useful for circadian disorders and insomnia patterns, not apnea scoring.
- Cheyne-Stokes respiration
- Crescendo-decrescendo breathing with central apneas, classically seen in heart failure with reduced ejection fraction.
- Obesity hypoventilation syndrome
- BMI of 30 or more with daytime PaCO2 of 45 mmHg or more and sleep-disordered breathing, without another cause of hypoventilation.
- Adaptive servo-ventilation
- Positive pressure device that adjusts support to stabilize ventilation in central sleep apnea; contraindicated in symptomatic heart failure with LVEF 45% or less.
- Congenital central hypoventilation
- Disorder linked to PHOX2B mutations causing inadequate automatic breathing during sleep; requires lifelong ventilatory support.
- Pediatric OSA severity
- In children, AHI 1-4.9 is mild, 5-9.9 moderate, and 10 or more severe; adenotonsillar hypertrophy is the most common cause.
- Adenotonsillectomy
- First-line surgical treatment for pediatric OSA with adenotonsillar hypertrophy; residual disease can persist, especially in obese children.
- CBT-I
- First-line insomnia treatment combining sleep restriction, stimulus control, cognitive restructuring, and relaxation; it outperforms hypnotics in the long term.
- Stimulus control
- Behavioral insomnia therapy using the bed only for sleep and intimacy, leaving bed when awake, and keeping a fixed wake time.
- Delayed sleep-wake phase
- Circadian disorder with late sleep onset and late awakening; treated with morning bright light and timed evening melatonin.
- Cataplexy
- Sudden emotion-triggered loss of muscle tone without loss of consciousness; its presence defines narcolepsy type 1.
- SOREMP
- Sleep-onset REM period occurring within about 15 minutes of sleep onset; two or more on MSLT support narcolepsy.
- Sodium oxybate
- Nightly divided-dose medication that treats cataplexy and excessive daytime sleepiness in narcolepsy.
- REM sleep behavior disorder
- Dream enactment with loss of REM atonia, often later in the night; associated with synucleinopathies and treated with melatonin or clonazepam.
- Restless legs syndrome
- Urge to move the legs that worsens at rest and in the evening and is relieved by movement; associated with iron deficiency.
- Periodic limb movements
- Repetitive limb movements lasting 0.5-10 seconds in sequences of four or more; scored during polysomnography and often seen with restless legs syndrome.
- Sleep terror
- NREM parasomnia arising from slow-wave sleep with abrupt arousal, autonomic surge, and amnesia for the event; common in children.
- Depression sleep findings
- Major depression is associated with reduced REM latency, increased REM density, and reduced slow-wave sleep; insomnia also predicts relapse.
- Prazosin
- Alpha-1 antagonist sometimes used for trauma-related nightmares in post-traumatic stress disorder, alongside imagery rehearsal therapy.
- Mandibular advancement device
- Oral appliance that advances the mandible to reduce upper airway collapse; useful for mild-to-moderate OSA and CPAP-intolerant patients.
- Maxillomandibular advancement
- Surgery that advances both jaws to enlarge the pharyngeal airway; among the most effective surgical options for selected OSA patients.
- Drug-induced sleep endoscopy
- Sedated endoscopy used to map levels of upper airway obstruction and guide surgical planning in OSA.
- PAP adherence threshold
- Common insurance criterion of CPAP use for 4 or more hours per night on 70% or more of nights over a defined period.